Philips and Ibex expand partnership to enhance AI-enabled pathology workflows for better patient care
Interoperable AI-powered digital pathology workflows support confident cancer diagnosis
Interoperable AI-powered digital pathology workflows support confident cancer diagnosis
See how to leverage multiplex immunoassays and proteomic profiling to enhance cancer diagnosis and treatment
With the help of Bio-Rad’s ultra-sensitive, multiplexed digital PCR system, Biodesix and its research partners are pursuing novel blood tests for the early detection and targeted treatment of lung cancer
Mark Hegarty, CEO of Dxcover, reveals how infrared spectroscopy coupled with machine learning could transform the future of cancer diagnosis
Faster, more accurate diagnoses are critical with non-small cell lung cancer, which accounts for about 85 percent of all lung cancer cases
The seamless integration of AI into digital pathology workflows aims to improve quality and efficiency of cancer diagnosis
Technology advances, coupled with collaborations between equipment makers and healthcare organizations, are improving early detection of blood cancers in Africa
Roche obtains CE certification for VENTANA CLDN18 (43-14A) RxDx Assay to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY
Aiforia Breast Cancer Grading AI solution is a part of the Aiforia Breast Cancer Suite, which also includes CE-IVD marked AI models for breast cancer biomarkers and the Aiforia Clinical Suite Viewer.
Biodesix and Memorial Sloan Kettering have joined forces to advance oncology diagnostics
Find out how research at HUB Organoids is paving the way for more effective cancer therapeutics
Capture and analyze mRNA of circulating tumor cells for ovarian and breast cancer diagnosis
Explore the latest developments in cancer research with fellow scientists, manufacturers, and regulatory experts